Pr Christophe Massard, Oncologue médical, expert vessie, expert prostate

Spécialité

Oncologue médical, expert vessie, expert prostate

Titre

Chef du Département des Essais Précoces (DITEP)

Hôpital

Gustave Roussy (Villejuif)

Derniers articles

First-in-human phase 1 study of KHK2455 monotherapy and in combination with mogamulizumab in patients with advanced solid tumors. (1 juil. 2025)
Induction of tertiary lymphoid structures in tumor microenvironment to improve anti-tumoral immune checkpoint blockade efficacy. (9 juin 2025)
Baseline CT-derived tumor burden and liquid biopsy as biomarkers to predict survival in patients with metastatic solid cancer. (7 juin 2025)
Age Does not Affect the Efficacy of Antibody Drug Conjugates, But is Associated with High-Grade Adverse Events in Patients with Cancer Enrolled in Early Phase Clinical Trials. (1 juin 2025)
Innovative, early-phase clinical trials of drug-radiotherapy combinations. (1 avr. 2025)